Epistaxis, also known as nosebleed, occurs due to rupturing of a small blood vessel in the lining of nose, as the interior of the nose is highly delicate and sensitive and could not tolerate certain factors that make them fragile and prone to burst resulting in bleeding. Nosebleeds are common mostly during winter, as more of the upper respiratory infections occur during this season.

The global Epistaxis market was valued at 140 million US$ in 2018 and will reach 210 million US$ by the end of 2025, growing at a CAGR of 5.7% during 2019-2025.
This report focuses on Epistaxis volume and value at global level, regional level and company level. From a global perspective, this report represents overall Epistaxis market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Epistaxis in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Epistaxis manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Smith & Nephew
Medline
Bristol-Myers Squibb Pharma Company
Ciron Drugs
King Pharmaceuticals, Inc
...

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Vasoconstrictors
Anesthetics
Antibiotic Ointments
Cauterizing Agents

Segment by Application
Pediatric
Adult